Zimbabwe has declined a major US healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to the United States' request for confidential information.
This move was revealed following a official document from December was leaked, which showed President Emmerson Mnangagwa deemed the deal was "lopsided".
An official spokesman later clarified that the United States was demanding access to health data for research and commercial gain but refused to share the benefits from any future vaccines.
"We are forced to start the difficult and regrettable process of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for further dialogue to find a deal acceptable to all parties so the country's critical HIV treatment initiative can proceed.
Broader Implications
This rejection comes after a comparable situation in Kenya, where a court blocked a similar deal with the US following legal challenges were raised about the security of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had overseen aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government deals to boost transparency and accountability.
According to statements, Sixteen African countries have so far agreed to similar agreements, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership might have yielded significant benefits for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, with no equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that might result from that shared data," his statement read.
"Put simply, our nation would provide the basic resources for medical research without any assurance that the end products would be accessible to our citizens if a future disease outbreak arise."
Sovereignty and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending frameworks already established through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to manage potential global health emergencies.
"This system is intended to ensure that when a nation contributes its samples, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to create them."
The government's concerns over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how future collaboration might be structured in a manner that respects the independence and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but suggested that talks need to persist given that a large portion of the country's HIV programmes depended on foreign aid.
"If specific concerns exist, such as those involving data governance or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," the group commented.
This impasse highlights the complex debate between accepting much-needed foreign assistance and protecting national sovereignty in an ever more data-driven world.